All the latest worldwide HIV and AIDS news, including treatment, prevention, and hepatitis and TB co-infections. News from our own team of writers plus articles we have selected from other sources.

aidsmap hiv & aids news


hiv & aids news selected from other sources

  • Achieving the 90-90-90 target
    London joins Fast-Track Cities initiative to reduce new HIV infections
    Mayor of London | 10 January 2018

    The Mayor of London, Sadiq Khan, today signed the Paris Declaration on Fast-Track Cities Ending the AIDS Epidemic, along with borough leaders, Public Health England and NHS England. Their ambition is to cut rates of new HIV infection in the capital and eliminate discrimination and stigma associated with the condition.

  • Policy
    Experts worry about consequences of Trump’s HIV/AIDS council firings
    Healio | 10 January 2018

    Without explanation, the Trump administration fired every remaining member of the Presidential Advisory Council on HIV/AIDS (PACHA) in letters on Dec. 27. The firings came 6 months after six members of the council publicly resigned in a letter that said President Donald J. Trump “simply does not care” about the subject of HIV/AIDS. Experts question the timing and meaning of the terminations by a White House now seen as detached from the HIV/AIDS community and possibly disdainful of science-based solutions to public health issues.

  • Pharmaceutical industry
    Teva Announces Exclusive Launch of a Generic Version of Reyataz® in the United States
    Teva press release | 10 January 2018

    Reyataz® had annual sales of approximately $402 million in the U.S., according to IMS data as of October 2017.

  • Harm reduction
    HIV spike linked to injection-drug use hits Cincinnati area
    USA TODAY | 10 January 2018

    The number of HIV cases linked to injection-drug use in Northern Kentucky and Southwest Ohio increased dramatically last year, according to public health officials. Now the federal Centers for Disease Control and Prevention is assisting with genetic testing to determine if the cases are connected.

  • Hepatitis C treatment
    India to launch national program to control viral hepatitis and aims to negotiate lower drug prices
    Pharma Letter | 09 January 2018

    The health ministry is set to roll out a National Program for the Control of Viral Hepatitis from the 2018-19 financial year. An antiviral treatment that costs anywhere between $63,000 and $94,000 for the full course in the USA and Europe is to be provided free of cost at all government health organizations.

  • PrEP
    Usage remains low for pill that can prevent HIV infection
    ABC News | 09 January 2018

    From gritty neighborhoods in New York and Los Angeles to clinics in Kenya and Brazil, health workers are trying to popularize a pill that has proven highly effective in preventing HIV but which — in their view — remains woefully underused.

  • Infectiousness and treatment as prevention
    Do you speak U=U? Talking to patients about treatment as prevention
    BHIVA | 09 January 2018

    NAM's Executive Director Matthew Hodson addresses the BHIVA Autumn Conference on treatment as prevention and U=U (Undetectable equals Untransmittable).

  • Pharmaceutical industry
    Brexit: Fears of disruption to flow of medicines means UK must stay under EU regulation, say government figures
    The Independent | 09 January 2018

    Looming disruption to the flow of medicines after Brexit means Britain must seek to stay under EU regulation, senior Government figures have conceded.

  • PrEP
    Kenya: HIV prevention pill yet to catch on
    Daily Nation | 08 January 2018

    Months after the launch of PrEP as a HIV-prevention measure, uptake is still lower than expected

  • Transgender people
    Trans Lives Matter
    Poz | 08 January 2018

    Fighting erasure and HIV.

Conference news

News from the 16th European AIDS Conference (EACS 2017).

HIV update

Sign up for HIV update, our fortnightly news bulletin for people living with HIV in the UK.

Achieving the 90-90-90 target

With advances in HIV testing, treatment and care, some countries are making great progress towards the UNAIDS 90-90-90 target.

New EUROBulletin

Read the December edition of the Sexual Health & HIV Policy EUROBulletin.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.